Eliquis Dosage
Generic name: apixaban
Drug class: Factor Xa inhibitors
Medically reviewed by A Ras MD.
Recommended Adult Dosing
Dosage forms: TAB: 2.5 mg, 5 mg
Thromboembolism/stroke prophylaxis
- [5 mg PO bid]
- Info: for non-valvular atrial fibrillation w/o mod-severe mitral stenosis or mechanical heart valve; decr. dose to 2.5 mg PO bid if at least 2 of the following: 80 yo or older, wt <60 kg, Cr >1.5; to convert from warfarin, D/C warfarin, then start apixaban when INR <2; to convert from other anticoagulants, D/C other anticoagulant, then start apixaban at next scheduled anticoagulant dose; hold tx >24h before surgery or invasive procedure w/ low bleeding risk or >48h if moderate-high bleeding risk
DVT prophylaxis
- [hip replacement]
- Dose: 2.5 mg PO bid x35 days; Start: 12-24h postop
- [knee replacement]
- Dose: 2.5 mg PO bid x12 days; Start: 12-24h postop
DVT/PE prophylaxis, recurrent
- [2.5 mg PO bid]
- Info: to convert from warfarin, D/C warfarin, then start apixaban when INR <2; to convert from other anticoagulants, D/C other anticoagulant, then start apixaban at next scheduled anticoagulant dose; hold tx >24h before surgery or invasive procedure w/ low bleeding risk or >48h if moderate-high bleeding risk
DVT/PE tx
- [5 mg PO bid]
- Start: 10 mg PO bid x7 days; Info: to convert from warfarin, D/C warfarin, then start apixaban when INR <2; to convert from other anticoagulants, D/C other anticoagulant, then start apixaban at next scheduled anticoagulant dose; hold tx >24h before surgery or invasive procedure w/ low bleeding risk or >48h if moderate-high bleeding risk
VTE prophylaxis, cardioversion
- [5 mg PO bid]
- Start: at least 3wk before cardioversion; Info: for pts w/ afib/flutter duration >48h or unknown; continue tx x4wk after procedure
Renal dosing
- [thromboembolism/stroke prophylaxis]
- Cr <1.5: 2.5 mg bid if also 80 yo or older and wt <60 kg; Cr >1.5: 2.5 mg bid if also 80 yo or older and/or wt <60 kg; CrCl <15: not defined
- HD: 2.5 mg bid if also 80 yo or older and/or wt <60 kg; no supplement after dialysis; PD: not defined
- [VTE prophylaxis, cardioversion]
- renal impairment: not defined
- HD/PD: not defined
- [all other indications]
- renal impairment: no adjustment
- HD: no adjustment; no supplement; PD: not defined
Hepatic dosing
- Child-Pugh Class A: no adjustment; Child-Pugh Class B: not defined; Child-Pugh Class C: avoid use
SRC: NLM .